A new vaccine for malaria has proven to be effective in clinical trials.
A new vaccine for malaria has proven to be effective in early stage clinical trials.
In 2010, malaria infected approximately 200 million people around the world with the parasitic disease reportedly causing 1 point 24 million deaths, mostly among young children.
The new vaccine treatment is called PfSPZ, and was tested by researchers from the National Institute of Allergy and Infectious Diseases.
Results from the very small clinical trial showed the vaccine was one hundred percent effective in the six people who took five doses, the highest amount.
One potential problem for distributing this new vaccine is that unlike other vaccines, which are administered by injecting them into the skin, PfSPZ needs to be injected intravenously.
Doctor Anthony Fauci, an immunologist and director of the National Institute of Allergy and Infectious Diseases said: “ if you want to do a mass vaccination program such as in Southern Africa where malaria is a very important problem, the logistics of that are somewhat complicated.”
It is also unknown how long the vaccine is effective and further studies will address this along with its efficacy against different strains of the malaria parasite.